JP2000316951A - Medical bag for chemicals solution - Google Patents
Medical bag for chemicals solutionInfo
- Publication number
- JP2000316951A JP2000316951A JP11130849A JP13084999A JP2000316951A JP 2000316951 A JP2000316951 A JP 2000316951A JP 11130849 A JP11130849 A JP 11130849A JP 13084999 A JP13084999 A JP 13084999A JP 2000316951 A JP2000316951 A JP 2000316951A
- Authority
- JP
- Japan
- Prior art keywords
- chamber
- sub
- solution
- drug
- medical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
Description
【０００１】[0001]
【発明の属する技術分野】本発明は、複数の室を備える
医療用薬液バックに関する。より詳細には、人体に点滴
により供給される輸液製剤、例えば、高カロリー輸液、
アミノ酸輸液、電解質輸液、その他の医療用輸液に反応
を生じ易い薬液を使用直前に注入するために好適な複数
の室を備える医療用薬液バッグに関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a medical solution bag having a plurality of chambers. More particularly, infusion preparations delivered by infusion to the human body, such as high calorie infusions,
The present invention relates to a medical drug solution bag having a plurality of chambers suitable for injecting a drug solution that easily reacts with an amino acid infusion, an electrolyte infusion, or another medical infusion immediately before use.
【０００２】[0002]
【従来の技術】従来、点滴により人体に供給される輸液
成分、例えば、アミノ酸液、ブドウ糖液等は、混合する
と変質するため、剥離可能な隔離手段により仕切られた
輸液バッグ内の複数の個室へそれぞれ収容し、使用時に
輸液バッグを外から押圧して隔離手段を剥離させて混合
することが工夫されており、このような技術は、例え
ば、特開昭６２−１７６４５１号公報、特開平８−１８
２７３９号公報、特表平８−５０９６３１号公報等に開
示されている。また点滴により患者に輸液を投与する場
合、患者の病態により、アミノ酸液、ブドウ糖液等の基
本液に少量の各種薬剤、例えば、トレースミネラル（微
量金属）、ビタミン剤、鎮痛剤、脂肪輸液、抗生物質、
ミネラル分、強心剤等を混合することが必要になる。通
常、基本液に少量の薬剤を混合する作業（混注）は、病
院内のクリーンブース内で行われ、混合すべき薬剤を注
射器を用いて輸液バッグ内の輸液へ注入する。この場
合、薬液の細菌感染を起こさないように注意深く行われ
る。2. Description of the Related Art Conventionally, infusion components supplied to the human body by infusion, for example, amino acid solutions, glucose solutions, and the like, are degraded when mixed, so that they are transferred to a plurality of private compartments in an infusion bag separated by a detachable separating means. It has been devised that the infusion bag is housed in each case and the infusion bag is pressed from the outside to separate and separate the separating means during use. Such techniques are disclosed in, for example, JP-A-62-176451 and JP-A-8-176451. 18
No. 2739, JP-T-8-509631, and the like. When an infusion is administered to a patient by intravenous drip, a small amount of various drugs such as trace minerals (trace metals), vitamins, analgesics, fat infusion, and antibiotics may be added to a basic solution such as an amino acid solution or a glucose solution depending on the patient's condition. material,
It is necessary to mix minerals, inotropic agents and the like. Normally, the operation of mixing a small amount of medicine with the basic solution (mix injection) is performed in a clean booth in a hospital, and the medicine to be mixed is injected into the infusion in the infusion bag using a syringe. In this case, care is taken so as not to cause bacterial infection of the drug solution.
【０００３】少量の各種の薬剤を輸液に混合する場合、
予め輸液に混合し投与まで長時間おくことは好ましくな
いことが多い。例えば、ビタミンＢ1は、高カロリー基
本液の中のアミノ酸の酸化防止剤として用いられる亜硫
酸塩によって分解が促進される。また、少量の各種薬剤
同志も混合によって汚濁が生じたり分解が促進されるも
のがあり、各薬剤の投与を時間差をおいて行うことが好
ましいとされるものもある。輸液は、通常１リットル程
度あるため、細かい作業を行うことが困難であり、一度
に混注作業が可能な薬剤の数も限定される。When mixing small amounts of various drugs into an infusion,
It is often unfavorable to mix with an infusion solution in advance and wait a long time before administration. For example, the degradation of vitamin B 1 is promoted by sulfites used as antioxidants for amino acids in a high calorie base solution. In addition, a small amount of various drugs may cause contamination or promote decomposition by mixing, and in some cases, it is preferable to administer each drug at a time interval. Since an infusion is usually about 1 liter, it is difficult to perform a detailed operation, and the number of drugs that can be co-injected at one time is limited.
【０００４】少量の各種の薬剤を基本液に混合する混注
作業は、比較的重量のある液体であるに拘わらず細心の
注意を払うことが必要な繁雑な作業であり、問題点を多
く含む。特公平５−５２７４８号公報は、注射器による
混注作業の不便さを解消するための混注用輸液バッグを
開示する。この混注用輸液バッグは、バッグ本体に瓶針
を設け、瓶針と薬剤を収納したバッグ本体内部の間に、
破断により瓶針と本体内部を連通させる流路を設けたも
のである。他方、近年、在宅医療が好まれ増加する傾向
にあり、家庭で患者に輸液を点滴により投与することが
多くなっている。輸液は、１日の投与量が約１ｋｇの輸
液バッグ２個の場合が多く、比較的重量があり、また在
宅医療用の輸液への薬剤の混注が病院で行われる場合、
混注後に変質しない間に患者に投与するため、病院から
輸液を頻繁に運搬することが必要となり、在宅看護の負
担を重くしている。[0004] The co-injection operation of mixing a small amount of various chemicals with the basic solution is a complicated operation that requires careful attention irrespective of the relatively heavy liquid, and has many problems. Japanese Patent Publication No. 5-52748 discloses a co-infusion infusion bag for eliminating the inconvenience of co-infusion work using a syringe. This infusion bag for co-infusion is provided with a bottle needle in the bag body, and between the bottle needle and the inside of the bag body containing the medicine,
A flow path is provided to connect the bottle needle and the inside of the main body by breaking. On the other hand, in recent years, home medical care has been favored and tended to increase, and infusions of infusions to patients at home have been increasing. Infusions are often two infusion bags with a daily dose of about 1 kg, are relatively heavy, and when co-infusion of drugs into infusions for home care is performed in hospitals,
Since the drug is administered to the patient without deterioration after co-injection, it is necessary to frequently transport the infusion from the hospital, which increases the burden of home nursing.
【０００５】[0005]
【発明が解決しようとする課題】本発明は、高カロリー
輸液、アミノ酸輸液、電解質輸液、その他の医療用輸液
を収容する輸液バッグ内へ患者に必要な少量の薬剤を混
注する作業を、病院において安全に且つ容易に行うこと
ができ、また在宅医療がなされる家庭において混注作業
を可能にする混注用の薬液バッグを提供することを目的
とする。本発明は、また複数の少量の薬剤を時間差をお
いて相互作用を排除し選択的に輸液に混合することが可
能な医療用薬液バッグを提供することを目的とする。本
発明の他の目的は、混注用薬液バッグの各室への薬液や
薬剤の充填のため複雑な構造の注入口を必要としない薬
液バッグを提供することである。本発明の更に他の目的
は、先端部が鋭利でない連通針を備えることにより複数
の少量の薬剤を基本液に容易に混入可能な薬液バッグを
提供することである。本発明のその他の目的は、以下の
説明において明らかにされる。SUMMARY OF THE INVENTION The present invention relates to an operation for injecting a small amount of a drug necessary for a patient into an infusion bag containing a high-calorie infusion, an amino acid infusion, an electrolyte infusion, and other medical infusions. It is an object of the present invention to provide a medicine bag for co-infusion that can be safely and easily performed, and that enables co-infusion work in a home where home medical care is performed. Another object of the present invention is to provide a medical solution bag capable of selectively mixing a plurality of small amounts of a drug with an infusion at a time difference while eliminating the interaction. Another object of the present invention is to provide a drug solution bag which does not require an inlet having a complicated structure for filling a drug solution or a drug into each chamber of the co-injection drug solution bag. Still another object of the present invention is to provide a drug solution bag which can easily mix a plurality of small amounts of drugs into a basic solution by providing a communication needle having a sharp tip. Other objects of the present invention will be clarified in the following description.
【０００６】[0006]
【解決するための手段】本発明の医療用薬液バックは、
可撓性樹脂フイルムにより包囲されそれぞれ液体を密封
し収容可能な第１室、第２室及び副室を有し、第１室及
び第２室は、それぞれ外部から薬液又は薬剤を充填可能
且つ閉鎖可能な第１注入口及び第２注入口を備え、副室
は、薬液を外部へ注出できる注出口を備え、第１室と副
室との間に第１イージーピールシールが配置され、第２
室と副室との間に第２イージーピールシールが配置さ
れ、第１室に収容された薬液が第１室の薬液を樹脂フィ
ルムを介し外部から押圧することにより第１イージーピ
ールシールを剥離させて副室へ流入可能であり、第２イ
ージーピールシールは、第２室内又は副室内の薬液を樹
脂フィルムを介し外部から押圧することによりを剥離さ
れ第２室と副室とを連通させることができる。The medical solution bag of the present invention comprises:
It has a first chamber, a second chamber, and a sub-chamber, each of which is surrounded by a flexible resin film and can seal and contain a liquid, and the first chamber and the second chamber can be filled with a drug solution or a drug from the outside and closed respectively. A possible first inlet and a second inlet are provided, the sub-chamber is provided with a spout capable of discharging a chemical solution to the outside, a first easy peel seal is arranged between the first chamber and the sub-chamber, 2
A second easy peel seal is disposed between the chamber and the sub-chamber, and the chemical contained in the first chamber presses the chemical in the first chamber from the outside via the resin film to peel off the first easy peel seal. The second easy-peel seal can be separated from the second chamber or the sub-chamber by pressing the chemical solution from the outside through the resin film to allow the second chamber and the sub-chamber to communicate with each other. it can.
【０００７】本発明の医療用薬液バッグは、好ましくは
次の構成を具備する。即ち、（ａ）第１注入口及び第２
注入口の少なくとも１つは、樹脂フイルムの一部分を切
断して薬液を室内へ注入しその後フイルムの切断部分付
近を密封するものである。（ｂ）第１注入口及び第２注
入口の少なくとも１つは、円筒形空間及び円筒形空間を
遮断するゴム栓を備える管部材から成り、円筒形空間
は、室内部と外部を連通可能であり、ゴム栓は、注射針
又は連通針により貫通可能であり、注射針又は連通針を
引き抜くことにより再シール可能である。（ｃ）注出口
は、輸液バッグの注入口部と接続又は連通可能な先端部
を備える連通針から成る。（ｄ）注出口は、円筒形空間
及び円筒形空間を遮断するゴム栓を備える管部材から成
り、円筒形空間は、副室内部と外部を連通可能であり、
ゴム栓は、連通針又は両頭針の一方の先端部により貫通
可能である。（ｅ）第１室、第２室及び副室は、２枚の
可撓性樹脂フイルムの周縁部を相互に強固に密着させ、
第１室と第２室の間に強固な密封部を設けることにより
形成されるものである。（ｆ）第１室及び第２室の一方
に固体の薬剤が収容される。（ｇ）薬液を収容可能な第
３室を更に有し、第３室と副室との間に第３イージーピ
ールシールが配置され、第３室に収容された第３薬液が
第３室を外部から押圧することにより第３イージーピー
ルシールを剥離させて副室へ流入可能である。（ｈ）そ
れぞれ別個の第３イージーピールシールにより副室との
間を区画される複数の第３室を含む。（ｊ）第１室と第
２室がスリットを介して連結されるか又は互いに分離さ
れており、別々に押圧し時間差をおいて各室の薬液を注
出することが容易にされる。The medical solution bag of the present invention preferably has the following configuration. That is, (a) the first inlet and the second
At least one of the inlets cuts a part of the resin film, injects a chemical solution into the room, and then seals the vicinity of the cut part of the film. (B) At least one of the first inlet and the second inlet is composed of a cylindrical space and a pipe member provided with a rubber stopper that blocks the cylindrical space, and the cylindrical space is capable of communicating between the inside of the room and the outside. Yes, the rubber stopper can be penetrated by an injection needle or a communication needle, and can be resealed by withdrawing the injection needle or the communication needle. (C) The spout comprises a communicating needle having a tip that can be connected or communicated with the inlet of the infusion bag. (D) the spout comprises a cylindrical space and a pipe member provided with a rubber stopper for shutting off the cylindrical space, the cylindrical space being capable of communicating between the sub-chamber interior and the outside;
The rubber stopper can be penetrated by one end of the communication needle or the double-ended needle. (E) the first chamber, the second chamber, and the sub-chamber firmly adhere the peripheral portions of the two flexible resin films to each other;
It is formed by providing a strong sealing portion between the first chamber and the second chamber. (F) One of the first chamber and the second chamber contains a solid drug. (G) further comprising a third chamber capable of storing a chemical solution, wherein a third easy peel seal is disposed between the third chamber and the sub-chamber, wherein the third chemical solution accommodated in the third chamber forms the third chamber; By pressing from the outside, the third easy peel seal can be peeled off and flow into the sub chamber. (H) Includes a plurality of third chambers separated from the sub-chamber by separate third easy peel seals. (J) The first chamber and the second chamber are connected via a slit or are separated from each other, so that it is easy to press them separately and to pour out the liquid medicine in each chamber with a time lag.
【０００８】[0008]
【作用】薬液バッグの第１室、第２室にそれぞれ患者の
病態に合わせた薬液又は薬剤が注入口を介し充填され、
注入口が流体密封状態に閉じられる。点滴の直前に、第
１室及び第２室の薬液が輸液バッグ内の輸液に混合され
る。第１室の薬液が外部から樹脂フィルムを介して押圧
され、液圧により第１イージーピールシールを剥離さ
せ、第１室と副室内が連通され、第１室の薬液が副室内
へ流入する。また注出口の連通針の先端部が輸液バッグ
のゴム栓を貫通して連通針の中空部を介し副室内部と輸
液バッグ内部が連通され、この状態で第１室及び副室を
外部から押圧することにより、副室内の薬液が輸液バッ
グ内の輸液中へ移動され混合される。第２室の薬液又は
薬剤は、副室又は第２室の薬液が外部から押圧され、第
２イージーピールシールを剥離させ、第２室と副室を連
通させ、第２室内の薬液が副室内へ流入する。副室内へ
流入した薬液は、薬液バッグが外部から押圧されること
により、連通針を介して輸液バッグ内の輸液中へ移動さ
れ混合される。The first and second chambers of the drug solution bag are filled with a drug solution or drug according to the condition of the patient via the inlet, respectively.
The inlet is closed in a fluid tight manner. Immediately before the infusion, the drug solutions in the first and second chambers are mixed with the infusion in the infusion bag. The chemical in the first chamber is pressed from outside via the resin film, the first easy peel seal is peeled off by the liquid pressure, the first chamber and the sub-chamber are communicated, and the chemical in the first chamber flows into the sub-chamber. In addition, the tip of the communication needle at the spout penetrates the rubber stopper of the infusion bag, and the inside of the sub-chamber and the inside of the infusion bag communicate with each other through the hollow portion of the communication needle. In this state, the first chamber and the sub-chamber are pressed from the outside. By doing so, the drug solution in the sub-chamber is moved and mixed into the infusion in the infusion bag. The chemical liquid or the medicine in the second chamber is pressed from the outside in the sub-chamber or the second chamber, peels off the second easy peel seal, makes the second chamber communicate with the sub-chamber, and the chemical in the second chamber is in the sub-chamber. Flows into The chemical solution flowing into the sub-chamber is moved into the infusion in the infusion bag via the communication needle and mixed by being pushed from outside.
【０００９】[0009]
【発明の実施の態様】次に本発明の実施の態様を図面を
参照して説明する。図１は、本発明の第１実施例の医療
用薬液バッグ１０の側面図である。薬液バック１０は、
可撓性樹脂フイルムにより包囲され、それぞれ患者の病
態に合わせて投与されるべき薬液又は薬剤、例えば、ビ
タミン剤、微量金属、強心剤、鎮痛剤等を収容可能な第
１室４２、第２室５２及び副室８２を備える。図１の実
施例において、薬液バッグ１０は、可撓性樹脂フイルム
のほぼ５角形の２枚の平らなシートを重ね、両シートを
ほぼ平行の２つの側縁部１２、１２、側縁部にほぼ垂直
に伸びる端縁部１４、側縁部に鈍角をなす２つの傾斜縁
部１６、１６をヒートシールにより流体密封可能に強固
に接着して形成される。薬液バッグ１０は、更に側縁部
１２、１２に沿って伸長し、長方形部分を第１室４２、
第２室５２にほぼ２分する仕切部２２を備える。仕切部
２２は、側縁部１２と同様に、ヒートシールにより流体
密封可能に強固に接着され形成される。重ねた２枚の平
らなシートに代えて、１枚の平らなシートを折り畳んで
重ねたシート、又は平らに圧しつぶした円筒形シートを
用いることができる。このような場合、連結されている
側縁部を結合する工程は不要である。Embodiments of the present invention will now be described with reference to the drawings. FIG. 1 is a side view of a medical drug solution bag 10 according to a first embodiment of the present invention. The chemical solution bag 10
The first chamber 42 and the second chamber 52 which are surrounded by a flexible resin film and can contain a drug solution or a drug, for example, a vitamin, a trace metal, an inotropic agent, an analgesic, etc., to be administered according to the condition of the patient. And a sub chamber 82. In the embodiment of FIG. 1, the liquid medicine bag 10 is formed by stacking two substantially pentagonal flat sheets of a flexible resin film, and placing the two sheets on two substantially parallel side edges 12, 12, and the side edges. An edge 14 extending substantially vertically and two inclined edges 16 forming an obtuse angle with the side edges are firmly adhered to each other in a fluid-tight manner by heat sealing. The drug solution bag 10 further extends along the side edges 12, 12, and forms a rectangular portion in the first chamber 42,
The second chamber 52 is provided with a partition part 22 that divides into approximately two. Like the side edge part 12, the partition part 22 is firmly bonded by heat sealing so as to be fluid-tight. Instead of two stacked flat sheets, one flat sheet may be folded and stacked, or a flat crushed cylindrical sheet may be used. In such a case, the step of joining the connected side edges is unnecessary.
【００１０】図１の医療用薬液バック１０において、３
角形の副室８２は、２枚の樹脂フィルムが重ねてヒート
シールされた２つの傾斜縁部１６、１６を備える。第１
室４２及び第２室５２は、それぞれ外部から薬液又は薬
剤を充填可能且つ閉鎖可能な第１注入口４６及び第２注
入口５６を備え、副室８２は、薬液を外部へ注出口可能
な注出口８４を備える。副室８２と第１室４２の間は、
第１イージーピールシール４４により仕切られ、副室８
２と第２室５２の間は、第２イージーピールシール５４
により仕切られる。第１イージーピールシール４４は、
第１室の薬液を樹脂フィルムを介し外部から押圧するこ
とにより剥離され、それにより第１室４２に収容された
薬液が剥離された第１イージーピールシール４４通り副
室８２へ流入可能である。同様に、第２イージーピール
シール５４は、第２室５２内又は副室８２内の薬液を樹
脂フィルムを介し外部から押圧することにより剥離さ
れ、第２室と副室とを流体連通させることができる。In the medical solution bag 10 shown in FIG.
The rectangular sub-chamber 82 has two inclined edges 16, 16 in which two resin films are overlapped and heat-sealed. First
The chamber 42 and the second chamber 52 have a first inlet 46 and a second inlet 56 which can be filled and closed with a drug solution or medicine from the outside, respectively. An outlet 84 is provided. Between the sub chamber 82 and the first chamber 42,
Partitioned by the first easy peel seal 44, the sub-chamber 8
A second easy peel seal 54 is provided between the second chamber 52 and the second chamber 52.
Partitioned by. The first easy peel seal 44
The chemical in the first chamber is peeled off by pressing it from the outside via the resin film, whereby the chemical contained in the first chamber 42 can flow into the sub-chamber 82 through the peeled first easy peel seal 44. Similarly, the second easy peel seal 54 is peeled off by pressing the chemical solution in the second chamber 52 or the sub-chamber 82 from the outside via the resin film, so that the second chamber and the sub-chamber can be in fluid communication. it can.
【００１１】図６Ａは、第１注入口４６又は第２注入口
５６として使用可能な注入口９６の斜視図、図６Ｂは、
図６Ａの線Ｆ−Ｆに沿う断面図である。注入口９６は、
樹脂製円筒部９７及び円筒部９７内部に軸線に垂直方向
に伸長して配置されるゴム膜部材９８を含む。円筒部９
７の一端は、外部へ開口し、円筒部の外周面は、端縁部
１４の重なり合うシートの間に配置されてシートに強固
に接着され、円筒部の他端は、第１室内部に開口され
る。薬液又は薬剤は、ゴム膜部材９８を配置する前に、
円筒部９７の中空部分を介し薬液バッグ内へ充填され
る。ゴム膜部材９８は、薬液又は薬剤を充填後に、固着
部材９９により円筒部９７内部に軸線に垂直方向に伸長
して配置される。ゴム膜部材９８は、第１室又は第２室
内へ追加の薬液を注入するため中空針（注射針）により
刺通可能である。FIG. 6A is a perspective view of an inlet 96 that can be used as the first inlet 46 or the second inlet 56, and FIG.
It is sectional drawing which follows the line FF of FIG. 6A. The inlet 96 is
It includes a resin cylindrical portion 97 and a rubber film member 98 disposed inside the cylindrical portion 97 so as to extend in a direction perpendicular to the axis. Cylindrical part 9
One end of the cylindrical portion 7 is open to the outside, the outer peripheral surface of the cylindrical portion is disposed between the overlapping sheets of the edge portion 14, and is firmly adhered to the sheet, and the other end of the cylindrical portion is open to the first chamber. Is done. Before disposing the rubber film member 98,
The liquid medicine bag is filled through the hollow portion of the cylindrical portion 97. The rubber film member 98 is disposed inside the cylindrical portion 97 by the fixing member 99 so as to extend in a direction perpendicular to the axis after the filling with the drug solution or the drug. The rubber membrane member 98 can be pierced by a hollow needle (injection needle) to inject an additional drug solution into the first chamber or the second chamber.
【００１２】図７Ａ〜Ｄは、第１室４２及び第２室５２
へ薬液Ｒ及びＳをそれぞれタブ１４６、１５６により形
成される注入口を使用し充填する工程を示す図である。
図７Ａは、薬液注入前の薬液バッグ１０の平面図、図７
Ｂは、第１室４２のタブ１４６を工具１６２により切離
して注入開口１４７を設ける工程を示す平面図、図７Ｃ
は、第１室への薬液Ｒの充填が済み、第２室へ注入開口
１５７を介し薬液Ｓを充填ノズル１６０を用いて注入す
る工程を示す平面図、図７Ｄは、注入開口１４７、１５
７の付近の樹脂フィルムをヒートシールし流体密封部１
４８、１５８を形成する工程を示す平面図である。充填
ノズル１６０は、図示しない薬液タンクから矢印Ｖで示
すように送られる薬液を第２室５２へ充填する。FIGS. 7A to 7D show a first chamber 42 and a second chamber 52.
It is a figure which shows the process of filling chemical | medical solution R and S using the injection hole formed of the tab 146,156, respectively.
FIG. 7A is a plan view of the drug solution bag 10 before the drug solution is injected, and FIG.
7B is a plan view showing a step of separating the tab 146 of the first chamber 42 with the tool 162 to provide the injection opening 147, and FIG.
FIG. 7D is a plan view showing a step of injecting the chemical solution R into the second chamber through the injection opening 157 using the filling nozzle 160 after filling the first chamber with the chemical solution R. FIG. 7D is a plan view showing injection steps 147 and 15.
7. Heat-sealing the resin film near 7
It is a top view which shows the process of forming 48,158. The filling nozzle 160 fills the second chamber 52 with a chemical solution sent from a chemical solution tank (not shown) as indicated by an arrow V.
【００１３】図８Ａは、第１室又は第２室から剥離され
た第１又は第２イージーピールシールを通り副室８２内
へ流入された薬液を薬液バッグ１０の外部へ注出する注
出口８４を示す。注出口８４は、鋭利な先端部８６を備
える中空針（注射針）８５により形成され、中空針８５
は、その基端において副室の傾斜縁部１６の２枚の樹脂
シートの間に配置されて樹脂シートに流体密封状態に強
固に結合される。中空針８５の先端部８６は、図示しな
い輸液バッグのゴム栓を貫通可能に鋭利にされ、通常
は、図８Ｂに示す安全キャップ８８により覆われてお
り、中空針８５の使用時に、安全キャップ８８が外され
る。鋭利な先端部８６を有する中空針に代えて、特表平
７−５０１９６１号公報に示される先の尖っていない連
通針を用いることができる。この場合、輸液バッグの注
入口部は、同じく、特表平７−５０１９６１号公報に示
される膜シールを備え、膜シールは、連通針を引き抜く
と再シール可能なスリットを有するものとされる。図９
は、注出口８４の変形例を示す部分断面を含む平面図で
ある。図９の注出口８４は、図８Ａに示す事例と同じ
く、鋭利な先端部８６を有する中空針８５を備え、且つ
先端部８６の周囲が保護筒８７により包囲される。保護
筒８７は、指等がその内部へ入り込まない限り鋭利な先
端部に触れない構造に形成され、且つ輸液バッグの注入
口部に係合する係合突起を備える。FIG. 8A shows a spout 84 for discharging the chemical solution flowing into the sub-chamber 82 through the first or second easy peel seal peeled off from the first chamber or the second chamber to the outside of the chemical bag 10. Is shown. The spout 84 is formed by a hollow needle (injection needle) 85 having a sharp tip portion 86, and the hollow needle 85
Is disposed between the two resin sheets at the inclined edge 16 of the sub-chamber at the base end thereof, and is firmly connected to the resin sheet in a fluid-tight manner. The distal end portion 86 of the hollow needle 85 is sharpened so as to penetrate a rubber stopper of an infusion bag (not shown), and is usually covered by a safety cap 88 shown in FIG. 8B. Is removed. Instead of the hollow needle having the sharp tip portion 86, a blunt communicating needle shown in Japanese Patent Publication No. 7-501961 can be used. In this case, the inlet of the infusion bag is provided with a membrane seal as disclosed in Japanese Patent Publication No. 7-501961, and the membrane seal has a slit that can be resealed when the communication needle is pulled out. FIG.
Is a plan view including a partial cross section showing a modification of the spout 84. 9A includes a hollow needle 85 having a sharp tip 86, as in the case shown in FIG. 8A, and the periphery of the tip 86 is surrounded by a protective tube 87. The protection cylinder 87 is formed so as not to touch the sharp tip end unless a finger or the like enters the inside thereof, and includes an engagement projection that engages with the injection port of the infusion bag.
【００１４】図２Ａ及びＢは、本発明の第２実施例の医
療用薬液バッグ１０を示し、図２Ａは、薬液バッグ１０
の平面図であり、図２Ｂは、薬液を収容し膨れた状態の
薬液バッグ１０の図２Ａの線Ｍ−Ｍにおける断面図であ
る。図２Ａ及びＢに示す薬液バッグ１０は、注入口４
６、５６の構造において図１の薬剤バッグと異なるが、
その他の構造においては、図１の薬剤バッグと同様であ
る。図２Ａ及びＢにおいて、注入口４６、５６は、いず
れも図７Ａ及びＢのものと同様に、薬液バッグの端縁部
１４又はその一部を切除し開口を形成し、その開口を介
して第１室及び第２室へそれぞれ薬液又は薬剤を充填
し、その後、開口周囲の樹脂フィルムをヒートシールす
るものである。FIGS. 2A and 2B show a medical solution bag 10 according to a second embodiment of the present invention, and FIG.
2B is a cross-sectional view taken along line MM in FIG. 2A of the drug solution bag 10 in a swollen state containing a drug solution. The chemical solution bag 10 shown in FIGS.
6 and 56 are different from the drug bag of FIG.
Other structures are the same as those of the medicine bag of FIG. In FIGS. 2A and 2B, the inlets 46 and 56 are formed by cutting off the edge portion 14 or a part thereof of the drug solution bag and forming the opening through the opening as in FIGS. 7A and 7B. The first chamber and the second chamber are filled with a chemical solution or a chemical, respectively, and then the resin film around the opening is heat-sealed.
【００１５】図３Ａ及びＢは、本発明の第３実施例の医
療用薬液バッグ１０を示し、図３Ａは、薬液バッグ１０
の平面図であり、図３Ｂは、第３実施例の変形例を示す
側面図である。図３Ａの薬液バッグ１０は、側縁部１
２、１２及び仕切部２２の構造において図１の薬剤バッ
グと異なるが、その他の構造においては、図１の薬剤バ
ッグと同様である。図３Ａの実施例においては、押し潰
し平らにされた円筒形樹脂フィルムが使用され、円筒形
樹脂フィルムの一方の端部を軸線にほぼ垂直に切断し、
ヒートシールして端縁部１４を形成し、他方の端部を軸
線に対し傾斜させて切断し、ヒートシールして傾斜端縁
部１６、１６を形成している。仕切部２２は、軸線に平
行に２枚の樹脂フィルムの間をヒートシールし接着して
形成される、仕切部にスリット２３が設けられている。
図３Ｂは、第１室と第２室の仕切部２２が、完全に分離
されている。図３Ａの薬液バッグは、スリット２３を利
用し第１室と第２室を手で引き離すことにより、また図
３Ｂの薬液バッグは、第１室と第２室が仕切部で分けら
れていることにより、各室を独立して押圧し、第１イー
ジーピールシール４４を第２イージーピールシール５４
から独立して剥離させ、時間差をおいて第１室と第２室
の薬液を注出することが容易である。FIGS. 3A and 3B show a medical solution bag 10 according to a third embodiment of the present invention, and FIG.
FIG. 3B is a side view showing a modification of the third embodiment. The chemical liquid bag 10 of FIG.
The structure of the medicine bag of FIG. 1 is different from that of the medicine bag of FIG. 1 in the structure of the medicine bag 2, 12 and the partition 22, but the other structure is the same as that of the medicine bag of FIG. In the embodiment of FIG. 3A, a crushed and flattened cylindrical resin film is used, and one end of the cylindrical resin film is cut substantially perpendicular to the axis,
The edge 14 is formed by heat sealing, the other end is cut while being inclined with respect to the axis, and the heat sealing is performed to form the inclined edges 16, 16. The partition part 22 is provided with a slit 23 in the partition part, which is formed by heat sealing and bonding between two resin films in parallel with the axis.
In FIG. 3B, the partition 22 of the first chamber and the second chamber is completely separated. 3A, the first chamber and the second chamber are separated by hand using the slit 23, and in the chemical bag of FIG. 3B, the first chamber and the second chamber are separated by a partition. , Each chamber is pressed independently, and the first easy peel seal 44 is replaced with the second easy peel seal 54.
From the first chamber and the second chamber with a time lag.
【００１６】図４は、本発明の第４実施例の医療用薬液
バッグ１０を示す平面図である。この薬液バッグ１０
は、第１室４２と第２室５２の間に第３室６２が設けら
れる。第３室６２と副室８２との間は、第３イージーピ
ールシール６４により仕切られる。第３イージーピール
シール６４は、第２イージーピールシール５４と同様
に、第３室６２内又は副室８２内の薬液を樹脂フィルム
を介し外部から押圧することによりを剥離され、第３室
と副室８２とを流体連通させることができる。第３室６
６は、薬液又は薬剤を第３室へ充填するための注入口６
６を備える。注入口６６は、図１又は図２の実施例と同
様に、図６又は図７に記載の注入口の構造を取ることが
できる。第３室６２は、複数個設けることが可能であ
る。この場合、各第３室と副室８２との間が、別個の第
３イージーピールシール６４により仕切られ、別々に剥
離可能とすることができる。各第３室は、異なる薬液又
は薬剤を収容するようにされる。副室８２その他の構造
は、図１〜図３のものと同様とすることができる。FIG. 4 is a plan view showing a medical solution bag 10 according to a fourth embodiment of the present invention. This chemical solution bag 10
The third chamber 62 is provided between the first chamber 42 and the second chamber 52. The third chamber 62 and the sub-chamber 82 are partitioned by a third easy peel seal 64. Similarly to the second easy peel seal 54, the third easy peel seal 64 is peeled off by pressing the chemical solution in the third chamber 62 or the sub chamber 82 from the outside via the resin film, and the third easy peel seal 64 is separated from the third chamber. The chamber 82 can be in fluid communication. Room 3
6 is an inlet 6 for filling the third chamber with a drug solution or drug.
6 is provided. The inlet 66 can take the structure of the inlet shown in FIG. 6 or 7 similarly to the embodiment of FIG. 1 or FIG. A plurality of third chambers 62 can be provided. In this case, the space between each of the third chambers and the sub-chamber 82 is separated by a separate third easy-peel seal 64, and can be separated separately. Each third chamber is adapted to contain a different drug solution or drug. The sub-chamber 82 and other structures can be the same as those shown in FIGS.
【００１７】図５は、本発明の第５実施例であり、第２
室５２内に副イージーピールシール５５が設けられ、第
２室５２の一部が第２の副室５３にされた点を除き、図
１の薬液バッグ１０と同様の構造を備える。第２の副室
５３へは、側縁部１２を切除する図７の形式の注入口を
介して薬剤Ｔが挿入されるか、又は副イージーピールシ
ール５６を形成する前に、第２注入口５６を介して第２
の副室５３へ薬剤Ｔを挿入される。副イージーピールシ
ール５５は、第２室５２内又は第２の副室８２内の薬液
を樹脂フィルムを介し外部から押圧することによりを剥
離され、第２室と第２の副室５３と副室８２とを流体連
通させることができる。FIG. 5 shows a fifth embodiment of the present invention.
A sub-easy peel seal 55 is provided in the chamber 52, and has the same structure as the chemical solution bag 10 in FIG. 1 except that a part of the second chamber 52 is changed to the second sub-chamber 53. The second sub-chamber 53 is filled with the drug T via an inlet of the type shown in FIG. 7 which cuts off the side edge 12, or before the secondary easy peel seal 56 is formed, the second inlet. Second through 56
Is inserted into the sub-chamber 53. The sub easy peel seal 55 is peeled off by pressing the chemical solution in the second chamber 52 or the second sub chamber 82 from the outside via the resin film, and the second chamber, the second sub chamber 53 and the sub chamber are separated. 82 can be in fluid communication.
【００１８】図１〜図５の実施例において、副室８２
は、注出口８４を介し、副室８４内の薬液を他容器内へ
供給可能にされる。注出口８４は、図８Ａ及びＢに示す
ように、鋭利な先端部８６を備える中空針８５、及びそ
の先端部８６を覆う安全キャップ８８により構成可能で
あり、また図９に示すように、鋭利な先端部８６を有す
る中空針８５及び先端部８６の周囲に配置される保護筒
８８により構成することができる。注出口８４のその他
の構造は、図６Ａ及びＢに示す注入口４６と同様の樹脂
製円筒部４７及び円筒部４７内部に配置されるゴム膜部
材４８を含む構造とすることができる。この場合、無菌
処理された両頭針の一方の先端部により注出口８４のゴ
ム膜部材を貫通し、他方の先端部により輸液容器のゴム
膜を刺通し、副室８２内の薬液を輸液容器内へ流入させ
る。In the embodiment shown in FIGS.
The liquid medicine in the sub chamber 84 can be supplied to another container through the spout 84. The spout 84 can be constituted by a hollow needle 85 having a sharp tip 86 as shown in FIGS. 8A and B, and a safety cap 88 covering the tip 86, and as shown in FIG. It can be constituted by a hollow needle 85 having a simple distal end portion 86 and a protective tube 88 arranged around the distal end portion 86. The other structure of the spout 84 can be a structure including the same resin-made cylindrical portion 47 as the inlet 46 shown in FIGS. 6A and 6B and the rubber film member 48 disposed inside the cylindrical portion 47. In this case, one end of the sterilized double-ended needle penetrates the rubber membrane member of the spout 84 and the other end pierces the rubber membrane of the infusion container, and the drug solution in the sub chamber 82 is introduced into the infusion container. Let it flow in.
【００１９】図１〜図５の実施例において、第１室、第
２室、第３室又は第２の副室に薬液又は薬剤を充填する
ための注入口４６、５６又は６６は、それぞれ図６Ａ及
びＢに示す樹脂製円筒部９７及び円筒部９７内部に配置
されるゴム膜部材９８を含む構造とすることが可能であ
る。また図６Ａ及びＢの構造に代えて、図７に示すよう
に樹脂フィルムの一部を切除して各室と外部を連通する
開口を形成し、その開口を介し、薬液又は薬剤を挿入
後、開口付近の樹脂フィルムをヒートシールにより液体
密封可能に強固に接着するものとすることが可能であ
る。図１〜５の実施例において、第１室、第２室、第３
室又は第２の副室は、薬液又は薬剤を収容され、副室８
２は、空の状態に構成されるが、副室８２に薬液又は薬
剤を収容することも可能である。In the embodiment shown in FIGS. 1 to 5, the inlets 46, 56 and 66 for filling the first chamber, the second chamber, the third chamber or the second sub-chamber with a chemical solution or a medicine are shown in FIG. 6A and 6B, a structure including a resin cylindrical portion 97 and a rubber film member 98 disposed inside the cylindrical portion 97 is possible. Also, instead of the structure of FIGS. 6A and 6B, as shown in FIG. 7, a part of the resin film is cut off to form openings for communicating the respective chambers with the outside, and after inserting a drug solution or a drug through the openings, The resin film in the vicinity of the opening can be firmly bonded so as to be liquid-sealed by heat sealing. In the embodiment of FIGS. 1 to 5, the first chamber, the second chamber,
The chamber or the second sub-chamber contains a drug solution or a drug, and the sub-chamber 8
2 is configured to be empty, but it is also possible to store a drug solution or a drug in the sub chamber 82.
【００２０】図１〜図５の実施例において、薬液バッグ
の外部からの力で開封可能の各イージーピールシール４
４、５４、５５、６４は、共通の圧力で開封されるよう
にし、同時に開封して薬液又は薬剤を混合し注出口から
外部へ供給可能にすることができる。またこれに代え
て、各イージーピールシールを開封する圧力を異なるも
のとし、各室を時間間隔をおいて開封し、各室の薬液又
は薬剤を順次供給可能な構造とすることができる。薬液
バッグの一部の室に凍結乾燥製剤などの固形薬剤を封入
しておくことや、生理食塩水と凍結乾燥製剤を別々の室
に封入しておき、必要時にイージーピールシールを剥離
させ溶解させることができる。イージーピールシールの
外側にタブを付けることによりイージーピールシールの
選択開封がより容易に行うことができる。In the embodiment shown in FIGS. 1 to 5, each of the easy peel seals 4 which can be opened by a force from the outside of the chemical solution bag.
4, 54, 55, 64 can be opened at a common pressure, and at the same time, can be opened to mix a medicinal solution or a medicament so that it can be supplied from the spout to the outside. Alternatively, the pressure for opening each easy peel seal may be different, each chamber may be opened at intervals of time, and a structure capable of sequentially supplying the drug solution or drug in each chamber may be adopted. A solid drug such as a lyophilized product can be sealed in some chambers of the drug solution bag, or physiological saline and a lyophilized drug can be sealed in separate chambers, and the Easy Peel seal can be peeled off and dissolved when necessary be able to. By attaching a tab to the outside of the easy peel seal, selective opening of the easy peel seal can be performed more easily.
【００２１】[0021]
【発明の効果】高カロリー輸液等の輸液は、それを用い
る患者の病態別に種々の薬剤、例えば、微量金属、ビタ
ミン剤、強心剤、鎮痛剤、脂肪輸液、を混ぜて投与され
るが、例えば、輸液の中のアミノ酸酸化防止剤の亜硫酸
塩によりビタミンＢ1の分解が進むこと等があり、輸液
に種々の薬剤を長時間混ぜた状態でおくことは不都合で
ある。また、混合される種々の薬剤は、それら同志を混
合すると、混濁や分解を生じることがある。本発明の複
数の室を有する医療用薬液バッグは、種々の薬剤をそれ
ぞれ別室に保存し、それらの薬剤同志の混合による混濁
や分解を生じないようにすると共に、輸液の使用直前又
は使用中に順次種々の薬液を輸液に混合することができ
る。薬液の混合作業は、注射器等の別個の機器を使用す
ることなく、容易に行うことができ、病院における混注
作業の負担が軽減される。The infusion such as high-calorie infusion is administered by mixing various drugs such as trace metals, vitamins, cardiotonic agents, analgesics, and fat infusions according to the condition of the patient using the infusion. There is such to advance the decomposition of vitamin B 1 by sulfite acid antioxidant in the infusion, it is inconvenient to place in a state of mixed long various agents infusion. In addition, when various drugs are mixed with each other, turbidity or decomposition may occur. The medical drug solution bag having a plurality of chambers of the present invention stores various drugs in separate chambers so that turbidity and decomposition due to mixing of the drugs do not occur, and immediately before or during use of the infusion solution. Various drug solutions can be sequentially mixed with the infusion. The mixing operation of the drug solution can be easily performed without using a separate device such as a syringe, and the burden of the co-injection operation in the hospital is reduced.
【００２２】家庭で患者に輸液を点滴により投与する場
合、比較的重量の大きい、例えば、１週間分１４Ｋｇ程
になる、輸液を運送業者により患者宅へ輸送し、本発明
の医療用薬液バッグに封入された混注すべき薬剤だけを
看護者が病院から持ち帰り家庭において混合することが
可能であり、在宅看護において、看護者の労力負担を大
きく軽減することができる。本発明によれば、輸液バッ
グ内へ患者に必要な微量薬剤を混注する作業を、病院又
は在宅看護がなされる家庭において容易に且つ安全に行
うことができる。When administering an infusion solution to a patient at home at home, the infusion solution is transported to the patient's home by a carrier, which is relatively heavy, for example, about 14 kg for one week, and is used in the medical solution bag of the present invention. It is possible for the nurse to take only the enclosed medicine to be co-injected and bring it home from the hospital and mix it at home, thereby greatly reducing the labor burden of the nurse in home nursing. ADVANTAGE OF THE INVENTION According to this invention, the operation | work which mix-injects a small amount of medicine required for a patient into an infusion bag can be performed easily and safely in a hospital or a home where home care is performed.
【００２３】本発明の薬液バッグは、各イージーピール
シールの剥離に必要な圧力を異なるものとし、薬液バッ
グの注出口を点滴用輸液バッグの混合用ゴム栓に刺通状
態とし、順次に薬液バッグの各室の薬液を点滴液に混合
し、患者に投与することができる。本発明薬液バッグ
は、薬剤の注入又は挿入のため複雑な構造の注入口を設
けることが不要である。In the drug solution bag of the present invention, the pressure required for peeling off each of the easy peel seals is made different, the injection port of the drug solution bag is pierced into the mixing rubber stopper of the infusion solution bag for infusion, and the drug solution bags are sequentially placed. Can be mixed with an infusion solution and administered to a patient. In the liquid medicine bag of the present invention, it is unnecessary to provide an injection port having a complicated structure for injecting or inserting a medicine.
【図１】図１は、本発明の第１実施例の医療用薬液バッ
グの側面図。FIG. 1 is a side view of a medical solution bag according to a first embodiment of the present invention.
【図２】図２Ａは、本発明の第２実施例の医療用薬液バ
ッグの側面図であり、図２Ｂは、 図２Ａの線Ｍ−Ｍに
沿って取った断面図。FIG. 2A is a side view of a medical solution bag according to a second embodiment of the present invention, and FIG. 2B is a cross-sectional view taken along line MM of FIG. 2A.
【図３】図３Ａは、本発明の第３実施例の医療用薬液バ
ッグの側面図であり、図３Ｂは、 第３実施例の変形例
の側面図。FIG. 3A is a side view of a medical solution bag according to a third embodiment of the present invention, and FIG. 3B is a side view of a modification of the third embodiment.
【図４】本発明の第４実施例の医療用薬液バッグの側面
図。FIG. 4 is a side view of a medical solution bag according to a fourth embodiment of the present invention.
【図５】本発明の第５実施例の医療用薬液バッグの側面
図。FIG. 5 is a side view of a medical solution bag according to a fifth embodiment of the present invention.
【図６】図６Ａは、注入口４６の斜視図、図６Ｂは、図
６Ａの線Ｆ−Ｆに沿う断面図である。6A is a perspective view of an inlet 46, and FIG. 6B is a cross-sectional view taken along line FF of FIG. 6A.
【図７】図７Ａ〜Ｄは、タブにより形成される注入口を
使用し第１室及び第２室へ薬液を充填する工程を示す図
であり、図７Ａは、薬液注入前のバッグ１０の側面図、
図７Ｂは、第１室４２のタブを切離して注入開口１４７
を設けた状態を示す側面図、図７Ｃは、第１室への薬液
Ｒの充填が済み、第２室へ注入開口１５７を介し充填ノ
ズル１６０から薬液Ｓを充填する工程を示す側面図、図
７Ｄは、注入開口１４７、１５７の付近の樹脂フィルム
を接着し流体密封部１４８、１５８を形成する工程を示
す側面図である。FIGS. 7A to 7D are diagrams showing a step of filling a first chamber and a second chamber with a drug solution using an inlet formed by a tab, and FIG. Side view,
FIG. 7B shows that the tab of the first chamber 42 is cut off and the injection opening 147 is opened.
FIG. 7C is a side view showing a state in which the first chamber is filled with the drug solution R, and a step of filling the second chamber with the drug solution S from the filling nozzle 160 via the injection opening 157. FIG. 7D is a side view showing a step of bonding resin films near injection openings 147 and 157 to form fluid-sealed portions 148 and 158.
【図８】図８Ａは、注出口を形成する中空針８５を示す
側面図、図８Ｂは、中空針の先端を覆う安全キャップ８
８の側面図である。FIG. 8A is a side view showing a hollow needle 85 forming a spout, and FIG. 8B is a safety cap 8 covering the tip of the hollow needle.
FIG. 8 is a side view of FIG.
【図９】図９は、注出口８４の変形例を示す部分断面を
含む側面図である。FIG. 9 is a side view including a partial cross section showing a modification of the spout 84.
１０：薬液バッグ、１２、１２：側縁部、１４、１４：
端縁部、１６、１６：傾斜縁部、２２：仕切部、４２：
第１室、４４：第１イージーピールシール、４６：第１
注入口、５２：第２室、５４：第２イージーピールシー
ル、５６：第２注入口、６２：第３室、６４：第３イー
ジーピールシール、８２：副室、８４：注出口、８５：
中空針、８８：安全キャップ、９７：樹脂製円筒部、９
８：ゴム膜部材、１４６、１５６：注入口、１４７、１
５７：注入開口、１４８、１５８：流体密封部、１６
０：充填ノズル、Ｒ，Ｓ：薬液、Ｔ：薬剤。10: chemical solution bag, 12, 12: side edge, 14, 14:
Edge, 16, 16: inclined edge, 22: partition, 42:
1st room, 44: 1st easy peel seal, 46: 1st
Inlet, 52: second chamber, 54: second easy peel seal, 56: second inlet, 62: third chamber, 64: third easy peel seal, 82: sub chamber, 84: outlet, 85:
Hollow needle, 88: safety cap, 97: resin cylinder, 9
8: Rubber film member, 146, 156: Injection port, 147, 1
57: injection opening, 148, 158: fluid seal, 16
0: filling nozzle, R, S: chemical, T: chemical.
Claims (8)
フイルムにより包囲されそれぞれ液体を密封し収容可能
な第１室、第２室及び副室を有し、第１室及び第２室
は、それぞれ外部から薬液又は薬剤を充填可能且つ閉鎖
可能な第１注入口及び第２注入口を備え、副室は、薬液
を外部へ注出できる注出口を備え、第１室と副室との間
に第１イージーピールシールが配置され、第２室と副室
との間に第２イージーピールシールが配置され、第１室
に収容された薬液が第１室の薬液を樹脂フィルムを介し
外部から押圧することにより第１イージーピールシール
を剥離させて副室へ流入可能であり、第２イージーピー
ルシールは、第２室内又は副室内の薬液を外部から押圧
することによりを剥離され第２室と副室とを連通させる
ことができる医療用薬液バッグ。1. A medical liquid bag, comprising a first chamber, a second chamber, and a sub-chamber surrounded by a flexible resin film and capable of sealing and storing a liquid, respectively. Has a first inlet and a second inlet, each of which can be filled and closed with a drug solution or drug from the outside, and the sub-chamber has a spout capable of discharging the drug solution to the outside, and the first chamber and the sub-chamber A first easy peel seal is disposed between the second chamber and the second chamber, and a second easy peel seal is disposed between the second chamber and the sub-chamber. The chemical contained in the first chamber is supplied with the chemical in the first chamber through a resin film. The first easy peel seal can be peeled off by being pressed from the outside and can flow into the sub-chamber, and the second easy peel seal can be peeled off by pressing the chemical solution in the second chamber or the sub-chamber from the outside. Medicine that can communicate between the room and the sub-room Liquid bag.
１つは、樹脂フイルムの一部分を切断して薬液を室内へ
注入しその後フイルムの切断部分付近を密封するもので
ある請求項１の医療用薬液バッグ。2. The method according to claim 1, wherein at least one of the first injection port and the second injection port cuts a part of the resin film, injects a chemical solution into the room, and then seals the vicinity of the cut part of the film. Medical solution bag.
１つは、円筒形空間及び円筒形空間を遮断するゴム栓を
備える管部材から成り、円筒形空間は、室内部と外部を
連通可能であり、ゴム栓は、注射針又は連通針により貫
通可能であり、注射針又は連通針を引き抜くことにより
再シール可能である請求項１又は２の医療用薬液バッ
グ。3. The at least one of the first inlet and the second inlet comprises a cylindrical space and a pipe member having a rubber stopper for shutting off the cylindrical space, and the cylindrical space communicates between the inside of the room and the outside. The medical solution bag according to claim 1 or 2, wherein the rubber stopper is penetrable by an injection needle or a communication needle, and is resealable by pulling out the injection needle or the communication needle.
又は連通可能な先端部を備える連通針から成る請求項１
乃至３のいずれか１項の医療用薬液バッグ。4. The infusion port comprises a communication needle having a distal end portion which can be connected or communicated with an injection port portion of the infusion bag.
4. The medical drug solution bag according to any one of items 3 to 3.
遮断するゴム栓を備える管部材から成り、円筒形空間
は、副室の内部と外部を連通可能であり、ゴム栓は、連
通針又は両頭針の一方の先端部により貫通可能である請
求項１乃至３のいずれか１項の医療用薬液バッグ。5. The spout comprises a cylindrical space and a pipe member provided with a rubber stopper for shutting off the cylindrical space. The cylindrical space is capable of communicating between the inside and the outside of the sub-chamber. The medical drug solution bag according to any one of claims 1 to 3, wherein the medical solution bag can be penetrated by one end of a needle or a double-ended needle.
性樹脂フイルムの周縁部を相互に強固に接着し、第１室
と第２室の間に強固な密封部を設けることにより形成さ
れるものである請求項１乃至５のいずれか１項の医療用
薬液バッグ。6. The first chamber, the second chamber, and the sub-chamber, the peripheral portions of the two flexible resin films are firmly bonded to each other, and a strong sealing portion is provided between the first chamber and the second chamber. The medical drug solution bag according to any one of claims 1 to 5, which is formed by providing:
収容される請求項１乃至６のいずれか１項の医療用薬液
バッグ。7. The medical solution bag according to claim 1, wherein one of the first chamber and the second chamber contains a solid drug.
有し、各第３室と副室との間にそれぞれ別個に第３イー
ジーピールシールが配置され、各第３室に収容された薬
液又は薬剤がそれぞれ別個の第３イージーピールシール
を剥離させて副室へ流入可能にされる請求項１乃至７の
いずれか１項の医療用薬液バッグ。8. The apparatus further comprises one or more third chambers capable of accommodating a chemical solution, wherein third easy peel seals are separately arranged between each of the third chambers and the sub chambers, and each of the third chambers is accommodated in each of the third chambers. The medical solution bag according to any one of claims 1 to 7, wherein the applied drug solution or drug is allowed to flow into the sub chamber by peeling off the separate third easy peel seal.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP13084999A JP4452903B2 (en) | 1999-05-12 | 1999-05-12 | Medical solution mixed solution bag |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP13084999A JP4452903B2 (en) | 1999-05-12 | 1999-05-12 | Medical solution mixed solution bag |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2000316951A true JP2000316951A (en) | 2000-11-21 |
| JP4452903B2 JP4452903B2 (en) | 2010-04-21 |
Family
ID=15044141
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP13084999A Expired - Fee Related JP4452903B2 (en) | 1999-05-12 | 1999-05-12 | Medical solution mixed solution bag |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4452903B2 (en) |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005288022A (en) * | 2004-04-05 | 2005-10-20 | Terumo Corp | Medical multi-chambered container |
| JP2008013204A (en) * | 2006-07-05 | 2008-01-24 | Univ Of Yamanashi | Liquid container |
| JP2008067848A (en) * | 2006-09-13 | 2008-03-27 | Hosokawa Yoko Co Ltd | Medical multi-chamber container |
| JP2008086487A (en) * | 2006-09-29 | 2008-04-17 | Takuya Saito | Container for drip infusion |
| JP2011509218A (en) * | 2007-12-27 | 2011-03-24 | バクスター・インターナショナル・インコーポレイテッド | Multi-chamber container |
| JP2011513155A (en) * | 2008-03-13 | 2011-04-28 | メドトロニック・ゾーメド・インコーポレーテッド | Flexible flat pouch with ports for mixing and dispensing powder and liquid mixtures |
| US8226628B2 (en) | 2004-08-04 | 2012-07-24 | Ajinomoto Co., Inc. | Communicating needle for connecting two or more containers to communicate |
| WO2012121094A1 (en) * | 2011-03-04 | 2012-09-13 | 学校法人久留米大学 | Albumin-containing intravenous injection |
| US9004761B2 (en) | 2006-05-01 | 2015-04-14 | Baxter International Inc. | Multiple chamber container with mistake proof administration system |
| CN106364738A (en) * | 2015-07-16 | 2017-02-01 | 日立造船株式会社 | Sealing bag, sealing package, sterile filling system and manufacture method for sealing package |
| KR101775593B1 (en) * | 2015-11-30 | 2017-09-07 | 정주연 | Pouch with atmospheric pressure |
-
1999
- 1999-05-12 JP JP13084999A patent/JP4452903B2/en not_active Expired - Fee Related
Cited By (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4481708B2 (en) * | 2004-04-05 | 2010-06-16 | テルモ株式会社 | Medical multi-chamber container |
| JP2005288022A (en) * | 2004-04-05 | 2005-10-20 | Terumo Corp | Medical multi-chambered container |
| US8226628B2 (en) | 2004-08-04 | 2012-07-24 | Ajinomoto Co., Inc. | Communicating needle for connecting two or more containers to communicate |
| US9004761B2 (en) | 2006-05-01 | 2015-04-14 | Baxter International Inc. | Multiple chamber container with mistake proof administration system |
| JP2008013204A (en) * | 2006-07-05 | 2008-01-24 | Univ Of Yamanashi | Liquid container |
| JP2008067848A (en) * | 2006-09-13 | 2008-03-27 | Hosokawa Yoko Co Ltd | Medical multi-chamber container |
| JP2008086487A (en) * | 2006-09-29 | 2008-04-17 | Takuya Saito | Container for drip infusion |
| JP2011509218A (en) * | 2007-12-27 | 2011-03-24 | バクスター・インターナショナル・インコーポレイテッド | Multi-chamber container |
| JP2011513155A (en) * | 2008-03-13 | 2011-04-28 | メドトロニック・ゾーメド・インコーポレーテッド | Flexible flat pouch with ports for mixing and dispensing powder and liquid mixtures |
| US10342733B2 (en) | 2008-03-13 | 2019-07-09 | Medtronic Xomed, Inc. | Flexible, flat pouch with port for mixing and delivering powder-liquid mixture |
| WO2012121094A1 (en) * | 2011-03-04 | 2012-09-13 | 学校法人久留米大学 | Albumin-containing intravenous injection |
| JP5967622B2 (en) * | 2011-03-04 | 2016-08-10 | 学校法人 久留米大学 | Preparation of albumin-containing intravenous injection |
| JPWO2012121094A1 (en) * | 2011-03-04 | 2014-07-17 | 学校法人 久留米大学 | Albumin-containing intravenous injection |
| CN106364738A (en) * | 2015-07-16 | 2017-02-01 | 日立造船株式会社 | Sealing bag, sealing package, sterile filling system and manufacture method for sealing package |
| JP2017024727A (en) * | 2015-07-16 | 2017-02-02 | 日立造船株式会社 | Hermetically sealed bag, hermetically sealed package, aseptic charging system and method for manufacturing hermetically sealed package |
| KR101775593B1 (en) * | 2015-11-30 | 2017-09-07 | 정주연 | Pouch with atmospheric pressure |
Also Published As
| Publication number | Publication date |
|---|---|
| JP4452903B2 (en) | 2010-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4930772B2 (en) | Communicating needle used to communicate two or more containers | |
| KR100654894B1 (en) | Multiple-chamber medical container and bag for enclosing same | |
| JP4236131B2 (en) | Medical container | |
| US4336802A (en) | Parenteral solution container for aseptic mixing | |
| JPS63317481A (en) | Vessel separating and storing active composition and mixing these composition | |
| JPS59500602A (en) | mixing device | |
| JP4697398B2 (en) | Preparation kit for injection and syringe containing medicine | |
| US5102408A (en) | Fluid mixing reservoir for use in medical procedures | |
| EP1228776B1 (en) | Infusion container | |
| JP4452903B2 (en) | Medical solution mixed solution bag | |
| KR20070086047A (en) | Medical liquid container and preparation-containing medical liquid container | |
| JPWO2005089697A1 (en) | Enteral nutrition bag | |
| JP4581331B2 (en) | Drug-filled multi-chamber bag | |
| JP4658570B2 (en) | Infusion tube, chemical solution administration set and connection adapter | |
| JP3668293B2 (en) | Injection container | |
| JP4273962B2 (en) | Flexible multi-chamber container | |
| JP3003949B2 (en) | Medical container | |
| JP3415714B2 (en) | Chemical transfer device and chemical transfer system | |
| JP3634560B2 (en) | Filled chemical container | |
| JP3903522B2 (en) | Multi-chamber separation container | |
| JP2001009006A (en) | Double cell container | |
| JPH0759865A (en) | Injection container | |
| CN212756454U (en) | Aseptic infusion soft bag for preparing medicines | |
| CN212490764U (en) | Safe type configurator convenient to medical personnel dispose and mix liquid medicine usefulness | |
| JPH04329955A (en) | Germ-free holding/mixing apparatus for two kinds of medicines held in individually sealed container |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20040917 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20040921 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20050524 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060428 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20081219 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090106 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090309 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20090526 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090821 |
|
| A911 | Transfer of reconsideration by examiner before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20090902 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20100105 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20100118 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130212 Year of fee payment: 3 |
|
| R150 | Certificate of patent (=grant) or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130212 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130212 Year of fee payment: 3 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |